Cingulate Therapeutics
focuses on the development of therapies for the treatment of central nervous system and neurobiological disorders... Read moreCingulate Therapeutics
focuses on the development of therapies for the treatment of central nervous system and neurobiological disorders... Read more
News
Oct 26, 2020
PR Newswire
Press Release: Cingulate Therapeutics : Cingulate Therapeutics Presents Results of Pivotal Phase 2 Clinical Trial for Lead ADHD Candidate CTx-1301 at the American Association of Child and Adolescent Psychiatry Annual Meeting
Jan 07, 2019
PR Newswire
Press Release: Cingulate Therapeutics : Cingulate Therapeutics to Present at Biotech Showcase 2019 in San Francisco
Oct 15, 2018
BioPortfolio
Cingulate Therapeutics: Cingulate Therapeutics LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250
Sep 07, 2018
FirstWord Pharma
Cingulate Therapeutics: BDD Pharma and Cingulate Therapeutics Announce License Agreement With OralogiK Enabled Triple Pulse Products
Jul 11, 2018
The Business Journals
Cingulate Therapeutics: Cingulate CEO: $7.5M fundraising round will help drive pharma growth in KC
Jul 11, 2018
MassDevice
Cingulate Therapeutics: Cingulate raises $7.5m for controlled-release ADHD therapy
Jul 11, 2018
The Business Journals
Cingulate Therapeutics: KCK pharma startup lands $7.5M, new board member
Jul 11, 2018
firstwordpharma
Cingulate Therapeutics: Cingulate Therapeutics Announces $7.5M Equity Investment from Werth Family Investment Associates
May 31, 2018
PharmiWeb
Cingulate Therapeutics: Cingulate Therapeutics Strengthens Leadership with Two New Board Appointments
Jan 15, 2018
ForImmediateRelease
Press Release: Cingulate Therapeutics : Cingulate Therapeutics Presents New Data from its First in Human Proof of Concept Trial of CTX-1301 at the 2018 APSARD Annual Meeting
Cingulate Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10